Engineering nanomedicines to reshape tertiary lymphoid structures: A new perspective on antitumor immunotherapy
Pharmacological Research · 2026-11 · 233 · 108462
DOI: 10.1016/j.phrs.2026.108462 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2026-11. Verfasst von Xueyi Song und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, PR China; Liaoning Key Laboratory of molecular targeted a…. Hauptthemen laut MEDLINE: Immunotherapy, Nanomedicine, Neoplasms, Tertiary Lymphoid Structures. Die Arbeit nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, PR China; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation, China Medical University, S…
- Department of Otorhinolaryngology, the First Affiliated Hospital of China Medical University, Shenyang, 110001, PR China. Electronic address: Jiali_han@163.com.
- Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, PR China. Electronic address: liheranmm@163.com.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Song, X., Li, Y., Ma, S., Xu, J., Gao, Y., Wei, Q., Ju, M., Jie, L., Bi, J., Han, J., Li, H., Zhao, L., & Wei, M. (2026). Engineering nanomedicines to reshape tertiary lymphoid structures: A new perspective on antitumor immunotherapy. Pharmacological Research, 233, 108462. https://doi.org/10.1016/j.phrs.2026.108462
Vancouver
Song X, Li Y, Ma S, Xu J, Gao Y, Wei Q, et al. Engineering nanomedicines to reshape tertiary lymphoid structures: A new perspective on antitumor immunotherapy. Pharmacological Research. 2026;233:108462. doi:10.1016/j.phrs.2026.108462
BibTeX
@article{Song2026,
author = {Song, Xueyi and Li, Yao and Ma, Shuai and Xu, Jiabin and Gao, Yuxing and Wei, Qian and Ju, Mingyi and Jie, Lili and Bi, Jia and Han, Jiali and Li, Heran and Zhao, Lin and Wei, Minjie},
title = {Engineering nanomedicines to reshape tertiary lymphoid structures: A new perspective on antitumor immunotherapy},
journal = {Pharmacological Research},
year = {2026},
volume = {233},
pages = {108462},
doi = {10.1016/j.phrs.2026.108462}
}
EUVIMED